July 11, 2013 – FDA accepts Eliquis Supplemental New Drug Application for review for prophylaxis of deep vein thrombosis following hip or knee replacement surgery.
July 11, 2013 – FDA accepts Eliquis Supplemental New Drug Application for review for prophylaxis of deep vein thrombosis following hip or knee replacement surgery.